BamSEC and AlphaSense Join Forces
Learn More

IN8bio Inc.

NASDAQ: INAB    
Share price (12/20/24): $0.25    
Market cap (12/20/24): $18.0 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 8-K 2 pages In8bio, Inc. Amendment No. 1 to Common Stock Purchase Warrant
12/34/56
EX-4.2
from 8-K 20 pages Series C Common Stock Purchase Warrant In8bio, Inc
12/34/56
EX-4.1
from 8-K 19 pages Common Stock Purchase Warrant In8bio, Inc
12/34/56
EX-4.3
from 10-K 10 pages Description of the Registrants’ Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 20 pages Common Stock Purchase Warrant In8bio, Inc
12/34/56
EX-4.2
from 8-K 20 pages Common Stock Purchase Warrant In8bio, Inc
12/34/56
EX-4.1
from 8-K 19 pages Common Stock Purchase Warrant In8bio, Inc
12/34/56
EX-4
from 10-K 7 pages Description of the Registrants’ Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.8
from S-3 18 pages In8bio, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of In8bio, Inc. Form of Debt Securities Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.7
from S-3 20 pages In8bio, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of In8bio, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.6
from S-3 20 pages In8bio, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of In8bio, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from S-3 45 pages In8bio, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 20 Debt Securities
12/34/56
EX-4.3
from S-1/A 20 pages Prefunded Common Stock Purchase Warrant In8bio, Inc
12/34/56
EX-4.3
from 10-K 7 pages Description of the Registrants’ Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.9
from S-8 13 pages In8bio, Inc. 2020 Employee Stock Purchase Plan Adopted by the Board of Directors: November 2, 2020 Approved by the Stockholders: November 5, 2020 Ipo Date: July 29, 2021
12/34/56
EX-4.6
from S-8 29 pages In8bio, Inc. 2020 Equity Incentive Plan Adopted by the Board of Directors: November 2, 2020 Approved by the Stockholders: November 5, 2020 Ipo Date: July 29, 2021
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.3
from S-1 14 pages Incysus Therapeutics, Inc. Warrant to Purchase Series a Preferred Stock Warrant Series: 2018-A No. Paw-[__] May 7, 2018 Void After May 7, 2023
12/34/56
EX-4.2
from S-1 59 pages Investors’ Rights Agreement
12/34/56
EX-4.3
from DRS 14 pages Incysus Therapeutics, Inc. Warrant to Purchase Series a Preferred Stock Warrant Series: 2018-A No. Paw-[__] May 7, 2018 Void After May 7, 2023
12/34/56